Physician

Philip Alain Gilly, MD

According to 2025 Medicare claims, Philip Gilly, MD (NPI: 1609849868) practices addiction medicine in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is HEGIRA HEALTH, INC (NPI: 1184684979; TIN: 382172765) and primary practice location at 48150-1000.

Gilly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 37 traditional Medicare patients, billed 148 HCPCS/CPT codes, and received $9,683 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,190 prescription claims across 69 beneficiaries totaling $110,725 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). Open Payments data shows 33 records totaling $551. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,568 and ending at $9,683. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,734 and ending at $110,725. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$13K$26K2015 Medicare payment: $2,568 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,532 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,552 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $24,775 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $25,812 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,592 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $8,694 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $9,683 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151635$2,568
20161533$2,532
2017N/RN/RN/R
20182858$3,552
201973324$24,775
202046350$25,812
2021N/RN/RN/R
20221662$5,592
20232596$8,694
202437148$9,683

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$111K$222K2015 Drug cost: $5,734 (USD; Tot_Drug_Cst)2016 Drug cost: $8,577 (USD; Tot_Drug_Cst)2017 Drug cost: $7,970 (USD; Tot_Drug_Cst)2018 Drug cost: $90,814 (USD; Tot_Drug_Cst)2019 Drug cost: $221,999 (USD; Tot_Drug_Cst)2020 Drug cost: $200,271 (USD; Tot_Drug_Cst)2021 Drug cost: $68,433 (USD; Tot_Drug_Cst)2022 Drug cost: $65,129 (USD; Tot_Drug_Cst)2023 Drug cost: $61,421 (USD; Tot_Drug_Cst)2024 Drug cost: $110,725 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151787$5,734
20161486$8,577
20171454$7,970
2018116658$90,814
20191441,499$221,999
2020961,562$200,271
202142622$68,433
202252780$65,129
202378960$61,421
2024691,190$110,725

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1465$94
96372Injection of drug or substance under skin or into muscle1448$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl2085,089$31,273
BrixadiBuprenorphine18490$30,939
SuboxoneBuprenorphine Hcl/Naloxone Hcl35919$15,036
ZubsolvBuprenorphine Hcl/Naloxone Hcl23545$7,626
AripiprazoleAripiprazole11300$595

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.33$551Indivior Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Philip Alain Gilly, MD?

Tedicare shows public-source Medicare data for Philip Alain Gilly, MD (NPI 1609849868), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Philip Alain Gilly, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Philip Alain Gilly, MD?

Philip Alain Gilly, MD is linked to HEGIRA HEALTH, INC (billing NPI 1184684979) in the available physician profile data.

Does Philip Alain Gilly, MD have Open Payments data?

Philip Alain Gilly, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.